Maternal preeclampsia modestly increases neonatal sepsis risk in infants up to 28 days of age.
A systematic review and meta-analysis examined the risk of neonatal sepsis in infants up to 28 days of age born to mothers with versus without preeclampsia. The study population included 1,513,008 neonates, of whom 65,848 were exposed to maternal preeclampsia, and identified 24,925 cases of neonatal sepsis. The primary outcome assessed was the risk of neonatal sepsis within the first month of life.
The analysis revealed a modestly increased risk of neonatal sepsis associated with maternal preeclampsia. The relative risk was 1.27 (95% CI: 1.02–1.56; p = 0.03). No specific adverse events, discontinuations, or tolerability data were reported for the intervention or exposure, as the study design was observational.
Key limitations included substantial heterogeneity (I² = 88%) and low certainty of evidence according to the GRADE framework. Associations were stronger in studies with lower Newcastle-Ottawa Scale scores, and findings were inconsistent across the included studies. Causality remains uncertain, and the underlying mechanisms are not fully elucidated.
In clinical practice, neonates born to mothers with preeclampsia may warrant closer clinical surveillance for early signs of infection. However, the modest effect size and low certainty of evidence suggest that these findings should not be overinterpreted as definitive proof of causation or a strong predictive marker for individual patients.